SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (2552)10/29/1997 6:24:00 PM
From: JOHN W.   of 6136
 
Henry, the article that raves about Ligand and also mentions AGPH in
not such a positive light that you have provided a link for is far from reality. For example, I would not take this man's advice based on extensive research too seriously since he did not even bother to learn how to spell the company's name.

" Augouron Pharmaceuticals shows what happens to a biotechnology company when it actually manages to get a significant product to market. Augouron's first commercial product, Viracept, a drug "

This is like the time several here on SI tried to lie and spread negative rumors about THYMITAQ, but repeatedly had the name and the usage incorrect.

Henry, you can do better. If you want to come on to another thread to peddle your company and try to ruin this thread's company at the same time, at least do a credible job.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News